                         SEQUENCE LISTING

<110>  CohBar, Inc.
 
<120>  CXCR4 ANTAGONIST PEPTIDES

<130>  32701/54031A/PCT

<150>  US 62/935,168
<151>  2019-11-14

<150>  US 63/002,338
<151>  2020-03-30

<160>  86    

<170>  PatentIn version 3.5

<210>  1
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is an amino acid having a non-polar side chain or is absent

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is an amino acid having a polar side chain

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is an amino acid having a non-polar side chain

<220>
<221>  MISC_FEATURE
<222>  (18)..(18)
<223>  Xaa is an amino acid having a polar side chain or is absent

<400>  1

Xaa Leu Xaa Arg Tyr His His Ser Xaa Arg Ser Ser Leu Arg Pro Tyr 
1               5                   10                  15      


Thr Xaa 
        


<210>  2
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  2

Met Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr 
1               5                   10                  15      


Thr Lys 
        


<210>  3
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  3

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  4
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  4

Leu Glu Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  5
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  d-Ala

<400>  5

Leu Glu Arg Tyr His His Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


<210>  6
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  6

Leu Arg Arg Tyr His His Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  7
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  7

Leu Asp Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  8
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  8

Leu Asp Arg Tyr His His Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  9
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is absent or Arg; Xaa is absent if Xaa 2 is absent.

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is absent or Arg; Xaa is absent if Xaa3 is absent

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is absent or Tyr; Xaa is absent if Xaa4 is absent

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is absent or His; Xaa is absent if Xaa5 is absent

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is absent or His

<400>  9

Xaa Xaa Xaa Xaa Xaa Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr Lys 
1               5                   10                  15      


<210>  10
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  10

Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr Lys 
1               5                   10                  15      


<210>  11
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  11

Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr Lys 
1               5                   10                  15  


<210>  12
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  12

Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr Lys 
1               5                   10                  


<210>  13
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  13

His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr Lys 
1               5                   10              


<210>  14
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  14

His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr Lys 
1               5                   10          


<210>  15
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  15

Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr Lys 
1               5                   10      


<210>  16
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  C terminal Amide

<400>  16

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  17
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is R or E

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is absent or Leu

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is absent or Arg; Xaa is absent if Xaa12 is absent

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is absent or Pro; Xaa is absent if Xaa13 is absent

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is absent or Tyr; Xaa is absent if Xaa14 is absent

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is absent or Thr; Xaa is absent if Xaa15 is absent

<400>  17

Leu Xaa Arg Tyr His His Ser Val Arg Ser Ser Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


<210>  18
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  18

Leu Glu Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


<210>  19
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  19

Leu Glu Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr 
1               5                   10                  15  


<210>  20
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  20

Leu Glu Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro 
1               5                   10                  


<210>  21
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  21

Leu Glu Arg Tyr His His Ser Val Arg Ser Ser Leu Arg 
1               5                   10              


<210>  22
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  22

Leu Glu Arg Tyr His His Ser Val Arg Ser Ser Leu 
1               5                   10          


<210>  23
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  23

Leu Glu Arg Tyr His His Ser Val Arg Ser Ser 
1               5                   10      


<210>  24
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  24

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


<210>  25
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  25

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr 
1               5                   10                  15  


<210>  26
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  26

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro 
1               5                   10                  


<210>  27
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  27

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg 
1               5                   10              


<210>  28
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  28

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu 
1               5                   10          


<210>  29
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  29

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser 
1               5                   10      


<210>  30
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is L or dA

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is R or E

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is R, D. or E

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Y or F

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is H, N or Q

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is H, N or Q

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is S or T

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is V or dA

<400>  30

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  31
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  31

Leu Arg Glu Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  32
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  32

Leu Arg Glu Tyr His His Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  33
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Ala

<400>  33

Ala Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  34
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<223>  D-Ala

<400>  34

Ala Glu Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  35
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  35

Ala Glu Arg Tyr His His Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  36
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  36

Leu Arg Asp Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  37
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  37

Leu Arg Asp Tyr His His Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  38
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  38

Leu Arg Arg Tyr His His Thr Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  39
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  39

Leu Glu Arg Tyr His His Thr Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  40
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  40

Leu Glu Arg Tyr His His Thr Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  41
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  41

Leu Arg Arg Tyr Asn His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  42
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  42

Leu Glu Arg Tyr Asn His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  43
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  43

Leu Glu Arg Tyr Asn His Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  44
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  44

Leu Arg Arg Tyr His Asn Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  45
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  45

Leu Glu Arg Tyr His Asn Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  46
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  46

Leu Glu Arg Tyr His Asn Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  47
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  47

Leu Arg Arg Tyr Gln His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  48
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  48

Leu Glu Arg Tyr Gln His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  49
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  49

Leu Glu Arg Tyr Gln His Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  50
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  50

Leu Arg Arg Tyr His Gln Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  51
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  51

Leu Glu Arg Tyr His Gln Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  52
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  52

Leu Glu Arg Tyr His Gln Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  53
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  53

Leu Arg Arg Phe His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  54
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  54

Leu Glu Arg Phe His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  55
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  55

Leu Glu Arg Phe His His Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  56
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  C terminal amide

<400>  56

Leu Glu Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  57
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  C terminal Amide

<400>  57

Leu Glu Arg Tyr His His Ser Ala Arg Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  58
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is R or E

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is V or dA

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is R, D, or E

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is S or T

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is S or T

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is R, D, or E

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is P or G

<220>
<221>  MISC_FEATURE
<222>  (15)..(15)
<223>  Xaa is Y or F

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is S or T

<400>  58

Leu Xaa Arg Tyr His His Ser Xaa Xaa Xaa Xaa Leu Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Lys 
    


<210>  59
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  59

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Phe Thr 
1               5                   10                  15      


Lys 
    


<210>  60
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  60

Leu Glu Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Phe Thr 
1               5                   10                  15      


Lys 
    


<210>  61
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  61

Leu Glu Arg Tyr His His Ser Ala Arg Ser Ser Leu Arg Pro Phe Thr 
1               5                   10                  15      


Lys 
    


<210>  62
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  62

Leu Arg Arg Tyr His His Ser Val Glu Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  63
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  63

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Glu Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  64
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  64

Leu Arg Arg Tyr His His Ser Ala Glu Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  65
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  65

Leu Arg Arg Tyr His His Ser Ala Arg Ser Ser Leu Glu Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  66
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  66

Leu Arg Arg Tyr His His Ser Val Asp Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  67
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  67

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Asp Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  68
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  68

Leu Arg Arg Tyr His His Ser Ala Asp Ser Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  69
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  69

Leu Arg Arg Tyr His His Ser Ala Arg Ser Ser Leu Asp Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  70
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  70

Leu Arg Arg Tyr His His Ser Val Arg Thr Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  71
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  71

Leu Arg Arg Tyr His His Ser Val Arg Ser Thr Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  72
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  72

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Ser 
1               5                   10                  15      


Lys 
    


<210>  73
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  73

Leu Glu Arg Tyr His His Ser Val Arg Thr Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  74
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  74

Leu Glu Arg Tyr His His Ser Val Arg Ser Thr Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  75
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  75

Leu Glu Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Pro Tyr Ser 
1               5                   10                  15      


Lys 
    


<210>  76
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  76

Leu Glu Arg Tyr His His Ser Ala Arg Thr Ser Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  77
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  77

Leu Glu Arg Tyr His His Ser Ala Arg Ser Thr Leu Arg Pro Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  78
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  78

Leu Glu Arg Tyr His His Ser Ala Arg Ser Ser Leu Arg Pro Tyr Ser 
1               5                   10                  15      


Lys 
    


<210>  79
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  79

Leu Arg Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Gly Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  80
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  80

Leu Glu Arg Tyr His His Ser Val Arg Ser Ser Leu Arg Gly Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  81
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  D-Ala

<400>  81

Leu Glu Arg Tyr His His Ser Ala Arg Ser Ser Leu Arg Gly Tyr Thr 
1               5                   10                  15      


Lys 
    


<210>  82
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  82

Tyr Ala Arg Ala Ala Ala Arg Gln Ala Arg Ala 
1               5                   10      


<210>  83
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is R, D, or E

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Y or F

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is S or T

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is V or dA

<220>
<221>  MISC_FEATURE
<222>  (10)..(10)
<223>  Xaa is S or T

<220>
<221>  MISC_FEATURE
<222>  (11)..(11)
<223>  Xaa is S or T

<220>
<221>  MISC_FEATURE
<222>  (14)..(14)
<223>  Xaa is P or G

<220>
<221>  MISC_FEATURE
<222>  (16)..(16)
<223>  Xaa is S or T

<220>
<221>  MISC_FEATURE
<222>  (17)..(17)
<223>  Xaa is absent or K

<400>  83

Leu Xaa Arg Xaa His His Xaa Xaa Arg Xaa Xaa Leu Arg Xaa Tyr Xaa 
1               5                   10                  15      


Xaa 
    


<210>  84
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  84

Tyr Gly Arg Lys Lys Arg Arg 
1               5           


<210>  85
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  85

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  86
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  86

Arg Arg Gln Arg Arg 
1               5   


